Kistler-Tiffany Companies’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $33K | Buy |
272
+50
| +23% | +$6.08K | 0.01% | 542 |
|
|
2023
Q1 | $34.1K | Hold |
222
| – | – | 0.01% | 476 |
|
|
2022
Q4 | $39.9K | Sell |
222
-123
| -36% | -$22.1K | 0.01% | 450 |
|
|
2022
Q3 | $41K | Hold |
345
| – | – | 0.01% | 402 |
|
|
2022
Q2 | $49K | Sell |
345
-8
| -2% | -$1.14K | 0.01% | 380 |
|
|
2022
Q1 | $61K | Hold |
353
| – | – | 0.01% | 367 |
|
|
2021
Q4 | $90K | Buy |
353
+15
| +4% | +$3.82K | 0.02% | 308 |
|
|
2021
Q3 | $130K | Buy |
338
+8
| +2% | +$3.08K | 0.03% | 234 |
|
|
2021
Q2 | $78K | Buy |
330
+22
| +7% | +$5.2K | 0.02% | 306 |
|
|
2021
Q1 | $40K | Buy |
308
+160
| +108% | +$20.8K | 0.01% | 362 |
|
|
2020
Q4 | $15K | Hold |
148
| – | – | ﹤0.01% | 459 |
|
|
2020
Q3 | $10K | Buy |
+148
| New | +$10K | ﹤0.01% | 473 |
|